Vensana Capital
Overview
Vensana Capital is a venture capital and growth equity investment firm dedicated to partnering with entrepreneurs who seek to transform healthcare with breakthrough innovations in medical technology . Launched in 2019, Vensana is actively investing in development and commercial stage companies across the medtech sector, including medical devices, data science-oriented solutions, life science tools & diagnostics, and tech-enabled services .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| SpyGlass Pharma | Feb 2026 | IPO | Co-investor |
| Alleviant Medical | Jan 2025 | VC Round | - |
| TYBR Health | Jul 2026 | Series A | Lead |
| Luna Diabetes | Aug 2025 | Series A | Lead |
| iVEAcare | Apr 2024 | Series A | Lead |
For institutional investors. Book with your work email.
Key People
Justin Klein
Co-Founder Managing Partner
Kirk Nielsen
Co-Founder Managing Partner
Bill Hoffman
Venture Partner
Ross D. Segan
Venture Partner
Amrinder Singh
Partner
Greg Banker
Partner
Maria Berkman
Partner
Mike Kramer
Partner
Steve Schwen
Partner and Chief Financial Officer
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Vensana Capital based?
Vensana Capital is headquartered in Minneapolis, Minnesota, United States.
When was Vensana Capital founded?
Vensana Capital was founded in 2019.
How many portfolio companies does Vensana Capital have?
Vensana Capital has 21 portfolio companies in Caplight's dataset.
What are some companies in Vensana Capital's portfolio?
Portfolio companies visible on Caplight include SpyGlass Pharma, Alleviant Medical, TYBR Health, Luna Diabetes, iVEAcare.
What was Vensana Capital's most recent investment shown here?
Vensana Capital's most recent investment in this portfolio sample was in TYBR Health in 2026.
What sectors does Vensana Capital focus on?
Vensana Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Vensana Capital focus on?
Vensana Capital typically invests at the MultiStage stage.
What is Vensana Capital's AUM?
Vensana Capital's assets under management are estimated between $500.0M and $1.0B.